Revolutionising Rare Disease Diagnostics
Millions of individuals affected by rare diseases (RD) face long diagnostic odysseys. Current tools like exome and short-read genome sequencing miss key variants, leaving many families without answers. ERDERA is here to change that. Together with leading genomics and multiomics experts, ERDERA is creating the most complete, innovative, and accessible diagnostic toolkit that can be used to offer hope and solutions to RD patients across the globe.
Our Mission
To enable faster, more accurate, and globally accessible RD diagnostics through cutting-edge (gen)omics.
Complete human genome analysis
Multi-omics innovation (transcriptomics, epigenomics and more)
Reduced diagnostic turnaround times
Global equity in diagnostics
Our Impact
Faster Diagnoses
Shorter journeys for patients and their families
More Accurate Results
Full genome resolution + improved
interpretation
Equity in Access
Cutting-edge technologies for all
underrepresented countries
Innovation at Scale
Establishing new global benchmarks in RD care
What’s New?
Long-read sequencing
PacBio & Oxford Nanopore platforms reveal previously hidden genetic variants
Optical Genome Mapping
A powerful new layer for the detection of structural variations
Multi-omics integration
Combining genomics, transcriptomics, and epigenomics to reduce the number of variants of unknown significance
Global access
Training and empowering underrepresented countries to join the diagnostic revolution
Call for Collaboration:
New Samples Needed
We are currently looking for new samples that fit our use cases, for which we can carry out long-read sequencing and optical genome mapping.
If you have potentially interesting cases, or if you are interested in collaborating, please do get in touch with us.
You might also be interested in
